Research ArticleCancer therapy

Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma

See allHide authors and affiliations

Sci. Signal.  11 Sep 2018:
Vol. 11, Issue 547, eaau5147
DOI: 10.1126/scisignal.aau5147

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article